Evidence map›Paper›PMID 39604626›Full record

ArticleGeroScience2025

Advancing prediction of age-related vascular cognitive impairment based on peripheral and retinal vascular health in a pilot study: a novel comprehensive assessment developed for a prospective workplace-based cohort (The Semmelweis Study).

Tamas Csipo, Agnes Lipecz, Peter Mukli, Anna Péterfi, Zsofia Szarvas, Anna Ungvari, Lamyae El Alaoui, Márton Sándor, Attila Kállai, Mónika Fekete and 9 more

Abstract read
In one paragraph

Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Tamas Csipo *Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary. csipo.tamas@semmelweis.hu.ORCID 0000-0003-2639-2404
Agnes Lipecz *Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Peter Mukli *Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Anna PéterfiInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Zsofia SzarvasInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Anna UngvariInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Lamyae El AlaouiInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Márton SándorInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Attila KállaiInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Mónika FeketeInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Gábor Á FülöpVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Stefano TarantiniVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Anna CsiszarVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Zoltán BenyóDepartment of Translational Medicine, Semmelweis University, Budapest, Hungary.
Péter SótonyiDepartment of Vascular and Endovascular Surgery, Semmelweis University, Budapest, Hungary.
Adam G TabakInstitute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Béla MerkelyHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Andriy YabluchanskiyVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Zoltan UngvariVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Funding

Cerebral microhemorrhages and gait dysfunction in agingR01AG055395 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CSISZAR, ANNA · 2017 to 2025
$2.3M
Age-related vascular cognitive impairment: role of endothelial senescenceR01AG068295 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CSISZAR, ANNA, UNGVARI, ZOLTAN ISTVAN · 2020 to 2024
$1.8M
The role of IGF-1 signaling in vascular smooth muscle cells in age-related vascular cognitive impairment and dementiaR01AG070915 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CONLEY, SHANNON M · 2021 to 2025
$1.8M
Radiation-induced astrocyte dysfunction and cognitive declineR01NS100782 · NINDS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI UNGVARI, ZOLTAN ISTVAN · 2018 to 2022
$1.7M
Chemotherapy-induced vascular cognitive impairment: role of endothelial senescenceR01CA255840 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CSISZAR, ANNA · 2021 to 2025
$1.6M
Cerebromicrovascular rejuvenation by heterochronic blood exchangeRF1AG072295 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CSISZAR, ANNA, UNGVARI, ZOLTAN ISTVAN · 2021 to 2021
$1.4M
Midlife Obesity, Neurovascular Senescence and Cognitive DeclineK01AG073614 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TARANTINI, STEFANO · 2021 to 2025
$601k
Targeting adipose tissue thermogenesis for age-related vascular cognitive impairmentK01AG073613 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BALASUBRAMANIAN, PRIYA · 2021 to 2025
$596k
Time-restricted feeding (TRF) for prevention of age-related vascular cognitive impairment and dementiaR03AG070479 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TARANTINI, STEFANO · 2022 to 2022
$290k
Division of Cancer Epidemiology and Genetics, National Cancer Institute R01CA255840National Research, Development and Innovation Office RRF-2.3.1-21-2022-00003National Research, Development and Innovation Office TKP2021-NKTA-47NCI NIH HHS R01 CA255840NIA NIH HHS K01 AG073613NIA NIH HHS K01AG073613NIA NIH HHS K01 AG073614NIA NIH HHS K01AG073614NIA NIH HHS R01 AG055395NIA NIH HHS R01AG055395NIA NIH HHS R01 AG068295NIA NIH HHS R01AG068295NIA NIH HHS R01 AG070915NIA NIH HHS R01AG070915NIA NIH HHS R03 AG070479NIA NIH HHS R03AG070479NIA NIH HHS RF1 AG072295NIA NIH HHS RF1AG072295NINDS NIH HHS R01 NS100782NINDS NIH HHS R01NS100782
6 · The paper itself

Abstract

With a growing elderly population in the European Union, age-related diseases associated with unhealthy aging pose increasing public health challenges, including a loss of independence and heightened societal burdens. The Semmelweis Study, a prospective occupational cohort study in Hungary, seeks to identify determinants of unhealthy aging, focusing on the complex relationship between lifestyle, environmental, occupational factors, and the development of chronic age-associated diseases, including age-related vascular cognitive impairment (VCI). The primary objective of this pilot study was to establish a robust, high-throughput assessment methodology to comprehensively evaluate both peripheral and cerebrovascular health to provide a solid foundation for the forthcoming Semmelweis Study framework. The study involved 49 participants aged 23 to 87 years, and it assessed multi-domain cognitive performance through an automated battery of tests (CANTAB). Vascular health was comprehensively evaluated using laser speckle contrast imaging (LSCI), flow-mediated dilation (FMD), static and dynamic retinal vessel analysis (SVA, DVA), and measurements of vascular stiffness. The retinal microvasculature, which closely mirrors the cerebral circulation in anatomy, physiology, and pathophysiology, provided a unique window for examination. Optical imaging through SVA and DVA enables the identification of structural and functional changes in the central nervous system's microcirculation, which are highly relevant to the pathogenesis of VCI. Subsequently, the collected measures were integrated into vascular health indices using principal component analysis (PCA) and the relationship to the age and cognitive status of study participants was explored. These comprehensive vascular health indices demonstrated a correlation not only with age but also with cognitive performance. This methodology holds promise for providing novel insights into the intricate interplay between vascular and cognitive health within the context of the Semmelweis Study.

Indexed as

AgingCognitive DysfunctionRetinal VesselsAdultAgedAged, 80 and overFemaleHumansHungaryMaleMiddle AgedPilot ProjectsProspective StudiesVascular StiffnessYoung AdultHealthy agingMicrocirculationVascular cognitive impairment and dementia

Identifiers

PMID39604626
PMCPMC11872852

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.